Erythrocin and Naproxen drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Erythrocin (erythromycin lactobionate) and Naproxen (naproxen). Common drug interactions include cardiac disorder among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Erythrocin and Naproxen. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Erythrocin?

Erythrocin has active ingredients of erythromycin lactobionate. It is often used in tooth abscess. eHealthMe is studying from 1,200 Erythrocin users. Check the latest studies of Erythrocin.

What is Naproxen?

Naproxen has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 72,034 Naproxen users. Check the latest studies of Naproxen.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

12 people who take Erythrocin and Naproxen together, and have interactions are studied.

Erythrocin and Naproxen drug interactions.

What are the common drug interactions of Erythrocin and Naproxen, by gender? *:

female:

Cardiac disorder
Cough
Drug dependence
Eating disorder
Hypertension (high blood pressure)
Insomnia (sleeplessness)
Mitral valve disease mixed (disease process involving one or more of the valves of the heart)
Muscle spasms (muscle contraction)
Myalgia (muscle pain)
Pain in extremity

male:

Chronic kidney disease
Death
Renal injury (kidney injury)
Lung neoplasm malignant (cancer tumour of lung)
Platelet count decreased
Septic shock (shock due to blood infection)

What are the common drug interactions of Erythrocin and Naproxen, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Chronic kidney disease
Renal injury (kidney injury)

30-39:

Drug dependence

40-49:

Chronic kidney disease
Death

50-59:

Palpitations (feelings or sensations that your heart is pounding or racing)
Anaemia (lack of blood)
Cardiac disorder
Hypertension (high blood pressure)
Mitral valve disease mixed (disease process involving one or more of the valves of the heart)
Muscle spasms (muscle contraction)
Myalgia (muscle pain)
Pain in extremity
Sinus arrhythmia (a naturally occurring variation in heart rate that occurs during a breathing cycle)
Type 2 diabetes mellitus

60+:

Interstitial lung disease
Pneumonia bacterial (pneumonia associated with bacterial infection)
Cough
Death
Lung neoplasm malignant (cancer tumour of lung)
Platelet count decreased
Productive cough
Pyrexia (fever)
Respiratory failure (inadequate gas exchange by the respiratory system)
Septic shock (shock due to blood infection)

What are the existing conditions these people have? *

Squamous Cell Carcinoma Of The Cervix (cervix cancer of a kind of epithelial cell): 2 people, 16.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 16.67%
Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 1 person, 8.33%
Renal Cell Carcinoma (a kidney cancer): 1 person, 8.33%
Pneumonia: 1 person, 8.33%
Multiple Myeloma (cancer of the plasma cells): 1 person, 8.33%
Inflammation: 1 person, 8.33%
Infection: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Erythrocin and Naproxen?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously